A graphic visualisation of bacteria in violet and blue tones.

Florey Institute of Infection

We are committed to understanding infectious disease at every level of human interaction to improve health outcomes around the world.

About us

Established in 2012, we take a novel holistic approach to accelerate research and medical practice into the diagnosis, causes, prevention and treatment of infectious diseases and antimicrobial resistance (AMR). 

About the Florey Institute

Our mission

We are cross-faculty, multi-disciplinary, research-led and inclusive. We are strongly committed to taking an integrated approach to the prevention and treatment of pathogenic microorganisms to improve human health.

Our mission

Our people

We comprise a wide range of expert academic and clinical colleagues from across the University of 91̽»¨ and the NHS.

Meet the Florey leadership team

Research themes

microscopic image of staph aureus labeled by fluorescence

Pathogen biology, antimicrobial resistance and diagnostics

We are committed to understanding pathogenesis and combating the threat of microbes and antimicrobial resistance (AMR).

Pathogen biology, AMR and diagnostics

host pathogen interaction

Host-pathogen interactions

Using our track record in pre-clinical and experimental medicine, our research is primed to inform the development of novel vaccines and therapeutic interventions against infectious diseases.

Host-pathogen interactions

GSD - Cities - Mountains and city view

Epidemiology and global health

We aim to use our expertise in pathogen biology and host-pathogen interactions to help address the high mortality and morbidity from infectious diseases in Low and Middle Income Countries (LMICs).

Epidemiology and global health

News

Professor Martha Clokie taking questions from the audience
Photograph: Professor Val Randall

Yorkshire Symposium 2024- Experts gather to discuss the rise of antimicrobial resistant superbugs

A recent symposium (Saturday 9 November) held at the University of 91̽»¨ brought together experts to discuss the global issue of antimicrobial resistance, often referred to as ‘superbugs’.
Pills

University of 91̽»¨ researchers awarded funding to develop new drugs to treat pneumonia

A team of researchers from the Florey Institute at the University of 91̽»¨ have been awarded PACE funding to develop new drugs to treat life-threatening infections, including pneumonia.

microscope image of MRSA bacteria

MRSA's double defence against antibiotics

Scientists have discovered the mechanism which allows the superbug Methicillin Resistant Staphylococcus aureus (MRSA) to become highly resistant to antibiotics, paving the way for new approaches to control infectious disease.
Fluorescent image

Florey scientists secure funding to explore a new antifungal therapeutic target

Congratulations to Simon Johnston who has successfully secured a grant from the Medical Research Council to investigate macrophage ridges as a new therapeutic target for fungal meningitis
A graphic visualisation of bacteria in violet and blue tones.